VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
13 hedge funds and large institutions have $29.1M invested in VIVEVE MED INC in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1.51% less ownership
Funds ownership: 54.39% → 52.88% (-1.5%)
19% less funds holding
Funds holding: 16 → 13 (-3)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
41% less capital inflows, than outflows
Capital inflows: $797K | Capital outflows: $1.36M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Granahan Investment Management
Waltham,
Massachusetts
|
+$452K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$202K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$113K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$5.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$928K |
| 2 |
SIM
Spark Investment Management
New York
|
-$142K |
| 3 |
Virtu KCG Holdings
New York
|
-$107K |
| 4 |
EEG
E.E. Geduld
|
-$89.3K |
| 5 |
Goldman Sachs
New York
|
-$53.6K |
VIVE Hedge Fund Activity: Q4 2016 in Review
13 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q4 2016, worth a combined $29.1M — down 29% from $40.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VIVE and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Granahan Investment Management, adding an estimated $452K. The largest seller was Pura Vida Investments, cutting an estimated $928K.
- 13 institutional investors held VIVEVE MED INC (VIVE) as of Q4 2016, down from 16 in Q3 2016.
- Funds reported $29.1M of VIVEVE MED INC stock for Q4 2016, down 29% quarter-over-quarter.
- 3 funds opened new VIVEVE MED INC positions in Q4 2016 and 5 closed out, a net change of -2 holders.
- The largest VIVEVE MED INC buyer in Q4 2016 was Granahan Investment Management, an estimated $452K added.
- The largest VIVEVE MED INC seller in Q4 2016 was Pura Vida Investments, an estimated $928K sold.
Based on aggregated 13F filings for Q4 2016.